These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30082285)

  • 1. Clinical and Molecular Correlates of Escherichia coli Bloodstream Infection from Two Geographically Diverse Centers in Rochester, Minnesota, and Singapore.
    Mendis SM; Vasoo S; Johnston BD; Porter SB; Cunningham SA; Menon SR; Teng CB; De PP; Patel R; Johnson JR; Banerjee R
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082285
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-
    Kanamori H; Parobek CM; Juliano JJ; Johnson JR; Johnston BD; Johnson TJ; Weber DJ; Rutala WA; Anderson DJ
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584139
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of ceftazidime-avibactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
    Johnston BD; Thuras PD; Johnson JR
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115034. PubMed ID: 32331800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.
    Drawz SM; Porter S; Kuskowski MA; Johnston B; Clabots C; Kline S; Ferrieri P; Johnson JR
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5331-9. PubMed ID: 26100703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ceftolozane-tazobactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
    Johnston BD; Thuras P; Johnson JR
    PLoS One; 2018; 13(7):e0200442. PubMed ID: 29990385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.
    Johnson JR; Johnston B; Kuskowski MA; Sokurenko EV; Tchesnokova V
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4471-80. PubMed ID: 25987621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.
    Merino I; Shaw E; Horcajada JP; Cercenado E; Mirelis B; Pallarés MA; Gómez J; Xercavins M; Martínez-Martínez L; De Cueto M; Cantón R; Ruiz-Garbajosa P;
    J Antimicrob Chemother; 2016 Aug; 71(8):2125-30. PubMed ID: 27494832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 21-Year Survey of Escherichia coli from Bloodstream Infections (BSI) in a Tertiary Hospital Reveals How Community-Hospital Dynamics of B2 Phylogroup Clones Influence Local BSI Rates.
    Rodríguez I; Figueiredo AS; Sousa M; Aracil-Gisbert S; Fernández-de-Bobadilla MD; Lanza VF; Rodríguez C; Zamora J; Loza E; Mingo P; Brooks CJ; Cantón R; Baquero F; Coque TM
    mSphere; 2021 Dec; 6(6):e0086821. PubMed ID: 34935444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and characteristics of multidrug-resistant Escherichia coli sequence type ST131 at two academic centers in Boston and Minneapolis, USA.
    Mahoney MT; Brigman HV; Johnston BD; Johnson JR; Hirsch EB
    Am J Infect Control; 2023 Apr; 51(4):434-439. PubMed ID: 35764181
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Hastak P; Fourment M; Darling AE; Gottlieb T; Cheong E; Merlino J; Myers GSA; Djordjevic SP; Roy Chowdhury P
    Emerg Microbes Infect; 2020 Dec; 9(1):1780-1792. PubMed ID: 32686595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive Genetic Commonality among Wildlife, Wastewater, Community, and Nosocomial Isolates of Escherichia coli Sequence Type 131 (
    Jamborova I; Johnston BD; Papousek I; Kachlikova K; Micenkova L; Clabots C; Skalova A; Chudejova K; Dolejska M; Literak I; Johnson JR
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061277
    [No Abstract]   [Full Text] [Related]  

  • 12.
    Johnson JR; Johnston B; Thuras P; Launer B; Sokurenko EV; Miller LG
    mSphere; 2016; 1(6):. PubMed ID: 27904884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
    Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
    PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.
    Matsumura Y; Johnson JR; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S; ;
    J Antimicrob Chemother; 2015; 70(6):1639-49. PubMed ID: 25687644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characteristics of Escherichia coli sequence type 131 and its H30 and H30Rx subclones: a multicenter study from Korea.
    Kim SY; Park YJ; Johnson JR; Yu JK; Kim YK; Kim YS
    Diagn Microbiol Infect Dis; 2016 Feb; 84(2):97-101. PubMed ID: 26643062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla
    Johnston BD; Thuras P; Porter SB; Clabots C; Johnson JR
    Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2069-2075. PubMed ID: 33893571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of CTX-M extended-spectrum beta-lactamases and sequence type 131 in Korean blood, urine, and rectal Escherichia coli isolates.
    Graham SE; Zhang L; Ali I; Cho YK; Ismail MD; Carlson HA; Foxman B
    Infect Genet Evol; 2016 Jul; 41():292-295. PubMed ID: 27101781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-
    Johnson JR; Porter S; Thuras P; Castanheira M
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections.
    Kim YA; Lee K; Chung JE
    BMC Infect Dis; 2018 Jun; 18(1):250. PubMed ID: 29859045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-onset extended-spectrum-β-lactamase-producing Escherichia coli sequence type 131 at two Korean community hospitals: The spread of multidrug-resistant E. coli to the community via healthcare facilities.
    Kim YA; Kim JJ; Kim H; Lee K
    Int J Infect Dis; 2017 Jan; 54():39-42. PubMed ID: 27865830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.